June 13, 2024 08:19 PM EDTUpdated 10:53 AM
Financing

Up­dat­ed: Telix Phar­ma­ceu­ti­cals pulls Nas­daq list­ing plans just be­fore trad­ing was to start

Lei Lei Wu

News Reporter

Kyle LaHucik

Senior Reporter

Telix Phar­ma­ceu­ti­cals is no longer go­ing to list on the Nas­daq, the com­pa­ny an­nounced Thurs­day evening, pulling its US IPO short­ly …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Lil­ly be­comes the lat­est phar­ma to tap Ope­nAI for help, this time for an­tibi­ot­ic work

Gink­go to cut at least 35% of staff in mul­ti-year re­struc­tur­ing plan

New can­cer biotech emerges from Stan­ford re­search, with help of No­bel lau­re­ate Car­olyn Bertozzi

Can CRISPR be giv­en twice? Small study from In­tel­lia sug­gests it can

Ar­row­head shelves one car­diometa­bol­ic drug can­di­date, fo­cus­es on an­oth­er

Ex-Meta sci­en­tists launch Evo­lu­tion­aryScale with $142M seed round, un­veil­ing next-gen AI mod­el for pro­tein de­sign

A service from the Financial Times